Journal
FRONTIERS IN MEDICINE
Volume 8, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2021.649408
Keywords
psoriasis; cutaneous and systemic; classification criteria; therapy; diagnosis
Categories
Funding
- National Natural Science Foundation of China [81930089]
Ask authors/readers for more resources
Psoriasis is a chronic inflammatory disease that affects approximately 0.1-1.5% of the global population, with classic skin manifestations of scaly erythematous plaques. It is often associated with comorbidities such as psoriatic arthritis, metabolic syndrome, diabetes, cardiovascular disease, nephropathy, bowel disease, and brain diseases. Classifying psoriasis as cutaneous or systemic may help in better understanding and managing the disease.
Psoriasis is a chronic multisystem inflammatory disease that affects similar to 0.1-1.5% of the world population. The classic cutaneous manifestation of psoriasis is scaly erythematous plaques, limited or widely distributed. Moreover, psoriasis could be associated with comorbidities like psoriatic arthritis, metabolic syndrome, diabetes, cardiovascular disease, nephropathy, bowel disease, and brain diseases. In this review, we suggest that psoriasis should be classified as cutaneous psoriasis or systemic psoriasis and propose the classification for distinction. This would help to better understand and manage psoriasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available